[HTML][HTML] Clinical advances of hypoxia-activated prodrugs in combination with radiation therapy

IN Mistry, M Thomas, EDD Calder, SJ Conway… - International Journal of …, 2017 - Elsevier
With the increasing incidence of cancer worldwide, the need for specific, effective therapies
is ever more urgent. One example of targeted cancer therapeutics is hypoxia-activated …

Microenvironment-induced cancer metastasis

EK Rofstad - International journal of radiation biology, 2000 - Taylor & Francis
Purpose: To present and evaluate clinical data suggesting that cancer metastasis may be
induced by the microenvironment of the primary tumour and to discuss possible …

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

DM Brizel, GS Sibley, LR Prosnitz, RL Scher… - International Journal of …, 1997 - Elsevier
Purpose: Tumor hypoxia adversely affects short term clinical radiation response of head and
neck cancer lymph node metastases and long term disease-free survival (DFS) in cervix …

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α

C Koumenis, C Naczki, M Koritzinsky… - … and cellular biology, 2002 - Taylor & Francis
Hypoxia profoundly influences tumor development and response to therapy. While progress
has been made in identifying individual gene products whose synthesis is altered under …

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

M Nordsmark, M Overgaard, J Overgaard - Radiotherapy and oncology, 1996 - Elsevier
Background and purpose: Hypoxic tumor cells are known to be relatively radioresistant. The
aim of the study was to correlate oxygenation status and radiation response in advanced …

Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma

H Kimura, RD Braun, ET Ong, R Hsu, TW Secomb… - Cancer research, 1996 - AACR
Hypoxia occurs in two forms in tumors. Chronic or diffusion-limited hypoxia is relatively well
characterized. In contrast, intermittent or perfusion-limited hypoxia is not well characterized …

Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma

MA Varia, DP Calkins-Adams, LH Rinker… - Gynecologic …, 1998 - Elsevier
Background. Tumor hypoxia may be associated with treatment resistance, cell proliferation,
and metastatic potential, which contribute to poor prognosis. Complementary techniques for …

Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors

JA Raleigh, SC Chou, GE Arteel… - Radiation …, 1999 - meridian.allenpress.com
Pimonidazole binding was compared with oxygen electrode measurements and with
measurements of the radiobiologically hypoxic fraction in C3H mammary tumors in which …

[HTML][HTML] Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures

KW Short, S Carpenter, JP Freyer, JR Mourant - Biophysical journal, 2005 - cell.com
Raman spectra of cells and nuclei from cultures in the plateau (nonproliferating) and
exponential (proliferating) phases of growth were measured and show that Raman …

[PDF][PDF] " Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways

C Koumenis, BG Wouters - Molecular Cancer Research, 2006 - Citeseer
Poor oxygenation (hypoxia) is present in the majority of human tumors and is associated
with poor prognosis due to the protection it affords to radiotherapy and chemotherapy …